Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,906 | 146 | 64.5% |
| Consulting Fee | $1,500 | 1 | 33.3% |
| Education | $101.15 | 6 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $1,738 | 16 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $715.75 | 22 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $346.82 | 9 | $0 (2024) |
| Mallinckrodt LLC | $290.94 | 27 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $232.72 | 13 | $0 (2021) |
| Amgen Inc. | $165.02 | 9 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125.06 | 5 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $110.16 | 6 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $97.26 | 6 | $0 (2022) |
| Keryx Biopharmaceuticals, Inc. | $89.78 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $349.90 | 13 | AstraZeneca Pharmaceuticals LP ($151.39) |
| 2023 | $522.06 | 14 | AstraZeneca Pharmaceuticals LP ($291.42) |
| 2022 | $43.70 | 3 | GlaxoSmithKline, LLC. ($18.00) |
| 2021 | $367.72 | 22 | AstraZeneca Pharmaceuticals LP ($95.85) |
| 2020 | $375.03 | 24 | AstraZeneca Pharmaceuticals LP ($88.87) |
| 2019 | $1,880 | 22 | Relypsa, Inc. ($1,596) |
| 2018 | $105.66 | 6 | OPKO Pharmaceuticals, LLC ($29.24) |
| 2017 | $863.58 | 49 | Mallinckrodt LLC ($272.82) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: CRITICAL CARE | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Nephrology | ||||||
| 05/02/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/30/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: CRITICAL CARE | ||||||
| 04/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DIABETES | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Nephrology | ||||||
| 01/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.37 | General |
| 01/08/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/13/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $126.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $56.91 | General |
| 10/19/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 07/25/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $20.20 | General |
| 06/28/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: NEPHROLOGY | ||||||
| 06/20/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Rare Disease | ||||||
| 05/03/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.68 | General |
| 04/19/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.79 | General |
| 04/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), LOKELMA | Food and Beverage | In-kind items and services | $39.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.77 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 504 | 1,380 | $172,560 | $86,375 |
| 2022 | 11 | 602 | 1,189 | $189,450 | $97,068 |
| 2021 | 12 | 764 | 1,412 | $410,377 | $138,250 |
| 2020 | 14 | 954 | 2,031 | $435,319 | $185,841 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 41 | 87 | $36,975 | $23,277 | 63.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 123 | 348 | $33,060 | $21,118 | 63.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 83 | 95 | $28,500 | $12,451 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 181 | $29,865 | $10,432 | 34.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 35 | 94 | $18,800 | $5,171 | 27.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 63 | 105 | $7,350 | $3,949 | 53.7% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 15 | 409 | $6,135 | $2,974 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $4,800 | $2,901 | 60.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 11 | 12 | $4,200 | $2,698 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $2,875 | $1,406 | 48.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 141 | 377 | $35,815 | $20,950 | 58.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 125 | $37,500 | $19,303 | 51.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 37 | 59 | $25,075 | $16,478 | 65.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 153 | $25,245 | $14,209 | 56.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 55 | 151 | $30,200 | $8,613 | 28.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 88 | 191 | $13,370 | $5,794 | 43.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $7,050 | $4,049 | 57.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 31 | $4,650 | $2,489 | 53.5% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 13 | 34 | $5,100 | $2,304 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $3,375 | $1,988 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 18 | $2,070 | $890.84 | 43.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 137 | 158 | $45,949 | $24,618 | 53.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 147 | 394 | $47,344 | $22,151 | 46.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 52 | 91 | $46,751 | $20,814 | 44.5% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 16 | 61 | $36,577 | $13,414 | 36.7% |
About Dr. Karim Bitar, M.D
Dr. Karim Bitar, M.D is a Internal Medicine healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1609032523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karim Bitar, M.D has received a total of $4,507 in payments from pharmaceutical and medical device companies, with $349.90 received in 2024. These payments were reported across 153 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,906).
As a Medicare-enrolled provider, Bitar has provided services to 2,824 Medicare beneficiaries, totaling 6,012 services with total Medicare billing of $507,534. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Hershey, PA
- Active Since 07/30/2008
- Last Updated 02/05/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609032523
Products in Payments
- Veltassa (Drug) $1,780
- LOKELMA (Drug) $382.30
- ACTHAR (Biological) $359.00
- FARXIGA (Drug) $333.45
- Not Product Related (Medical Supply) $222.92
- JYNARQUE (Drug) $164.13
- Auryxia (Drug) $133.27
- Velphoro (Drug) $109.37
- SAMSCA (Drug) $108.50
- BENLYSTA (Biological) $87.84
- Parsabiv (Biological) $83.35
- AURYXIA (Drug) $53.77
- Parsabiv (Drug) $44.94
- TERLIVAZ (Drug) $42.10
- KRYSTEXXA (Biological) $37.82
- Ultomiris (Drug) $37.57
- Kerendia (Drug) $36.63
- SYSTEM ONE (Device) $26.62
- Rayaldee (Drug) $25.82
- Ozempic (Drug) $21.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hershey
Dr. Ayodele Ayoola, M.d, M.D
Internal Medicine — Payments: $256,536
Shin Mineishi, Md, MD
Internal Medicine — Payments: $83,814
Dr. David Nguyen, Md, MD
Internal Medicine — Payments: $81,987
Dr. Sarah Hussain, Md, MD
Internal Medicine — Payments: $64,341
Mauricio Sendra Ferrer, M.d, M.D
Internal Medicine — Payments: $43,136
Dr. Michael Farbaniec, Md, MD
Internal Medicine — Payments: $20,179